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Introduction: Pre-naïve B cells represent an intermediate stage in human B-cell development with some functions
of mature cells, but their involvement in immune responses is unknown. The aim of this study was to determine
the functional role of normal pre-naïve B cells during immune responses and possible abnormalities in systemic
lupus erythematosus (SLE) that might contribute to disease pathogenesis.
Methods: Pre-naïve, naïve, and memory B cells from healthy individuals and SLE patients were stimulated through
CD40 and were analyzed for interleukin-10 (IL-10) production and co-stimulatory molecule expression and their
regulation of T-cell activation. Autoreactivity of antibodies produced by pre-naïve B cells was tested by measuring
immunoglobulin M (IgM) autoantibodies in culture supernatants after differentiation.
Results: CD40-stimulated pre-naïve B cells produce larger amounts of IL-10 but did not suppress CD4+ T-cell
cytokine production. Activated pre-naïve B cells demonstrated IL-10-mediated ineffective promotion of CD4+ T-cell
proliferation and induction of CD4+FoxP3+ T cells and IL-10 independent impairment of co-stimulatory molecule
expression and tumor necrosis factor-alpha (TNF-α) and IL-6 production. IgM antibodies produced by differentiated
pre-naïve B cells were reactive to single-stranded deoxyribonucleic acid. SLE pre-naïve B cells were defective in
producing IL-10, and co-stimulatory molecule expression was enhanced, resulting in promotion of robust CD4+
T-cell proliferation.
Conclusions: There is an inherent and IL-10-mediated mechanism that limits the capacity of normal pre-naïve B
cells from participating in cellular immune response, but these cells can differentiate into autoantibody-secreting
plasma cells. In SLE, defects in IL-10 secretion permit pre-naïve B cells to promote CD4+ T-cell activation and may
thereby enhance the development of autoimmunity.Introduction
B-cell maturation in adults occurs in steps. First, in the
bone marrow, stem cells undergo a series of precursor
stages during which they rearrange their immunoglobulin
(Ig) genes to generate a wide range of unique antigen-
binding specificities to develop into immature/transitional
B cells. Then, in the periphery, they mature from transi-
tional to fully mature naïve B cells. Each developmental
step is tightly controlled by the expression and function of* Correspondence: hangrae2@snu.ac.kr; leejisoo@ewha.ac.kr
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creativecommons.org/publicdomain/zero/1.0/the B-cell receptor (BCR) [1]. In mice, transitional B cells
can be subdivided into two developmental subsets, T1 and
T2, based on expression of CD21 and IgD. CD24hiC-
D21loIgDlo T1 and CD24hiCD21hiIgDhi T2 cells appear to
have different population dynamics, and require different
maturation signals [2]. This multistep development process
during the maturation from transitional B cells into naïve
B cells has also been identified recently in humans. Based
on CD38 expression levels, human peripheral blood imma-
ture B cells could be subdivided into CD27−CD38hiIgD+
transitional B cells and CD27−CD38intIgD+ pre-naïve B
cells [3, 4]. The comprehensive phenotyping and initial
functional analysis clearly demonstrated that pre-naïve B
cells were a maturation intermediate between transitional
and naïve B cells with unique properties and functions.le distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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including pre-naïve B cells, express CD5, whereas in
mice, CD5 is expressed on specialized B-cell subset B-1
B cells [3, 5].
The essential role of mature B cells is the production
of antigen (Ag)-specific antibodies (Abs) during humoral
immunity by differentiating into plasma cells [6]. B cells
also mediate many other functions essential for immune
homeostasis. B cells are required for initiation of T-cell
immune responses by presenting Ags, providing co-
stimulation, and producing cytokines to activate and
expand effectors and memory T-cell populations [7]. In
addition, B cells can negatively regulate immune re-
sponses by directly inhibiting CD4+ T cells and by indu-
cing regulatory T cells (Tregs) through production of the
cytokine interleukin (IL)-10 [8]. These effector and
regulatory B-cell functions contribute to both normal
immune regulation and also immunopathology [7, 9].
Though immature, peripheral B cells during development
have a distinguished role in immune responses apart from
the mature B cells. They elicit T cell-independent rapid
antibody responses to polysaccharides, lipids, and other
non-protein antigens which cannot bind to major histo-
compatibility complex (MHC) molecules [10]. In mice,
immature B cells with specialized functions were identi-
fied. Marginal zone (MZ) B cells and B-1 B cells known to
elicit T cell-independent responses to antigens of microbes
in mucosal tissues and microbes that enter peritoneum
have been reported [11, 12]. Distinct IL-10-producing
regulatory B cells (Bregs) with immature phenotype also
have been recently identified in mice and also in humans
[13, 14]. However, functions of peripheral immature B
cells during normal immune responses are less well char-
acterized and remain to be delineated in humans.
In this respect, pre-naïve B cells are an interesting hu-
man peripheral immature B-cell population worthy of
further investigation. Pre-naïve B cells were phenotypic-
ally distinct from transitional and naïve B cells, express-
ing intermediate levels of CD38, CD10, CD9, and the
ABCB1 transporter, and were also shown to be capable
of differentiating into naïve B cells [3]. Pre-naïve B cells
manifested a unique set of functional characteristics [3].
These cells had typical characteristics of immature B
cells with shorter life span and defective responses to
BCR stimulation. However, pre-naïve B cells were com-
parable to adult B cells in their capacity to respond to
signaling through CD40. Moreover, collaboration with
activated CD4+ T cells resulted in their differentiation
into plasma cells with the secretion of Abs. Uniquely,
pre-naïve B cells expressed CD5, a marker of the B-1
subset of murine B cells, which can function as a nega-
tive regulator of BCR signaling and promote mainten-
ance of tolerance to auto-Ag [15–17]. Because of these
unique functional characteristics, pre-naïve B cells havethe potential to perform specialized functions during nor-
mal immune responses, not fully explored previously. In
this study, we set out to determine the functional role of
pre-naïve B cells during normal immune responses by ac-
tivating pre-naïve B cells through CD40. In addition, we
carried out experiments by using pre-naïve B cells from
patients with systemic lupus erythematosus (SLE) to deter-
mine the role of these cells during pathologic immunity.
Methods
Isolation of human B and T cells
Blood samples were obtained from 50 healthy adult do-
nors and from nine patients with SLE. Healthy individ-
uals included 21 men and 29 women with a mean age of
29 years (range of 25–35 years). Individuals who were
taking immunosuppressive drugs or who had a disease
potentially affecting the immune system were excluded.
Patients with SLE included one man and eight women
with a mean age of 40 years (range of 25–64 years). All
patients with SLE had active disease at the time of the
blood sample collection (an SLE Disease Activity Index
score of 12–26) and received low-dose glucocorticoid
and hydroxychloroquine. One patient was taking myco-
fenolate mofetil in addition to the above treatment. All
patients and healthy volunteers provided written in-
formed consent prior to sample collection. This work
was approved by the institutional review board of Ewha
Womans University Hospital and the institutional review
board of Seoul National University Hospital. Peripheral
blood mononuclear cells were isolated by centrifugation
on Biocoll Separating solution (Biochrom, Cambridge,
UK), and B cells were enriched by using Rosette Sep hu-
man B-cell enrichment cocktails (StemCell Technology,
Vancouver, BC, Canada). Enriched B cells were stained
with a combination of anti-CD20-PerCP, anti-CD27-FITC,
and anti-CD38-PE-Cy7 (all from BD Biosciences, Franklin
Lakes, NJ, USA). Cells were sorted into CD20+CD27−
CD38lo naïve, CD20+CD27−CD38Int pre-naïve, and CD20+
CD27+ memory B cells by using a BD FACSAriaIII™ and
very narrow gates centered around the median CD38
fluorescence intensity of each B-cell subset. CD4+CD25−
T cells were sorted after staining with a combination of
anti-CD4-APC-Cy7 and anti-CD25-PE.
Cell culture
Human CD154 expressing L cells (CD154-L cells, kindly
provided by Rizgar A. Mageed, Queen Mary University
of London) were cultured in Dulbecco’s modified Eagle’s
medium containing 5 % fetal bovine serum (FBS) (Life
Technologies, Carlsbad, CA, USA). The expression of
CD154 was routinely checked by flow cytometry. Puri-
fied human T and B cells were co-cultured in RPMI
1640 containing 10 % FBS (Life Technologies) in 96-well
plates at 3 × 104 cells/200 μl. For stimulating B cells,
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irradiated with 60 Gy and then co-cultured with sorted
B cells.
Cell functional assays
To measure IL-10 production by B cells, CD154-L cells
were co-cultured with sorted B cells for 3 days and with
50 ng/ml phorbol-12-myristate-13-acetate (PMA) (Sigma-
Aldrich, St. Louis, MO, USA), 1 μg/ml ionomycin (Sigma-
Aldrich), and Golgistop (BD Biosciences) in the last 6
hours of culture. Cells were fixed, permeabilized, and
stained with anti-human CD19-PE, IL-10-Alexa647,
interferon-gamma (IFN-γ)-FITC monoclonal Abs or iso-
type controls. Intracellular cytokine was assayed by using
a flow cytometer. Alternatively, the amount of IL-10 was
measured in the culture supernatants before PMA, iono-
mycin, and Golgistop by enzyme-linked immunosorbent
assay (ELISA) (R&D Systems, Minneapolis, MN, USA).
To measure the influence of activated B cells on CD4+
T-cell activation, CD154-L cells were co-cultured with
sorted CD4+CD25− T cells and B cells at a ratio of 1:10:10
(CD154-L cells: B cells: effector T cells) in the presence of
suboptimal stimulation with soluble anti-CD3 (5 μg/ml)
and anti-CD28 (10 μg/ml) for 5 days. Sorted autologous
effector T cells were labeled with 3 μM carboxyfluorescein
diacetate (Life Technologies) before co-culture with B
cells. Proliferation of T cells by CFSE (carboxyfluorescein
succinimidyl ester) dilution was assayed by flow cytome-
try. The same culture condition was used to measure
T-cell cytokine production. Intracellular IFN-γ and tumor
necrosis factor-alpha (TNF-α) and the cytokines in the
culture supernatants were measured by same methods
employed in IL-10 measurement. For identification of
CD4+ T cells, T cells were stained with anti-CD3-APC, as
CD4 is downregulated after activation. To measure the in-
fluence of activated B cells on CD4+FoxP3+ T-cell differ-
entiation, CD154-L cells were co-cultured with sorted
CD4+CD25− T cells and B cells at a ratio of 1:10:10
(CD154-L cells: B cells: effector T cells) in the presence of
optimal stimulation with anti-CD3/CD28-coated beads at
a ratio of 1:320 (beads: T cells). For identification of CD4+
FoxP3+ T cells, T cells were stained with anti-CD3-APC
and FoxP3-FITC. To induce in vitro differentiation of B
cells into plasma cells, sorted B cells were co-cultured
with 5 Gy-irradiated autologous effector T cells at a ratio
of 1:1 in a 96-well round-bottom tissue culture plate pre-
coated with 10 μg/ml anti-CD3 Abs (clone OKT3,
eBioscience, San Diego, CA, USA) in the presence of sol-
uble anti-CD28 Abs (5 μg/ml, clone CD28.2, eBioscience)
in 96-well round-bottom tissue culture plates for 11 days.
In some experiments, B cells were stimulated with 200
ng/ml IL-21 (Life Technologies) and 2 μg/ml anti-CD40
(R&D Systems) to induce differentiation in the presence
or absence of 10 μg/ml anti-IL-10 (clone JES3-9D7, BDBiosciences). For analysis of accessory molecule expres-
sion, B cells were cultured in the presence of CD154-L
cells for up to 2 days, and CD80, CD86, CD54, human
leukocyte antigen (HLA)-DR expression was determined
by flow cytometry after staining the cells with monoclonal
Ab anti-CD80-PE, anti-CD86-PE, anti-HLA-DR-V450, or
anti-CD54-PE. Recombinant human IL-10 (100 ng/ml,
R&D Systems), anti-IL-10 (10 μg/ml, BD Biosciences), and
anti-IL-10Rα (100 ng/ml, R&D Systems) blocking Abs
were added where indicated. The amounts of IL-6 and
TNF-α in the culture supernatants were analyzed by
multiplex assay with Luminex (Bio-Rad Laboratories,
Hercules, CA, USA).Flow cytometry
Cells were acquired on an LSRII flow cytometer (BD
Biosciences), and data were analyzed by using FlowJo 9.6
software (Tree Star Inc., now part of FlowJo, LLC,
Ashland, OR, USA).Measurement of antibody reactivity
Cell culture supernatants were screened for Ab reactivity
to single-stranded DNA (ssDNA), double-stranded DNA
(dsDNA), and histone by ELISA. All samples were di-
luted (1/2) with dilution buffer (2 % bovine serum albu-
min, 3 mM EDTA, 0.05 % Tween 20, and 0.1 % gelatin,
all from Sigma-Aldrich) and incubated overnight. Micro-
well plates were washed and incubated with a secondary
alkaline phosphatase-labeled goat anti-human IgM Ab
(Southern Biotechnology, Birmingham, AL, USA) over-
night, followed by development with para-nitrophenyl
phosphate (Sigma-Aldrich). Serially diluted sera from pa-
tients with SLE were used for preparing standard curves.
All samples were analyzed in duplicate.Examination of immunoglobulin heavy chain
complementary region 3
Single-cell polymerase chain reaction was used to amp-
lify rearranged heavy chain Ig genes from genomic DNA
as previously described [4]. Sequences were compared
with germline Ig genes by using the web-based analysis
program JoinSolver [18, 19] to examine IgH CDR3 (IgH
CDR3) characteristics.Statistical analysis
All values are expressed as mean ± standard error of
mean. Mean fluorescence intensity values were calcu-
lated as the geometric mean. Data were compared by
using the paired two-tailed Student’s t test. P values of
less than 0.05 were considered significant. All statistical
analyses were performed by using GraphPad Prism 5.0
(GraphPad Software, Inc., La Jolla, CA, USA).


























































































































Fig. 1 (See legend on next page.)
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Fig. 1 Identification of CD40-activated human B cells which produce high levels of interleukin-10 (IL-10). a Peripheral blood CD20+ B cells were
stained for CD20, CD27, and CD38 and gated as previously shown [3]. A representative dot plot shows the CD27−CD38lo naïve (N), CD27−CD38Int
pre-naïve (PN), CD27−CD38hi transitional (T), and CD27+ memory (M) B-cell subsets (n = 50). b Representative contour plot showing the frequencies
of IL-10-producing B cells measured by intracellular cytokine staining of naïve, pre-naïve, and memory B-cell populations following stimulation with
CD154-L cells for 72 hours. c The frequencies of IL-10-producing B cells in B-cell subsets as described in (b) (n = 10, cumulative data from nine
independent experiments). d Supernatants from cultures as described in (b) and (c) were tested for the presence of IL-10 by enzyme-linked
immunosorbent assay (ELISA). e Frequencies of IL-10-producing pre-naïve B cells following stimulation with L cells with and without CD154
expression as described in (b) (n = 3, cumulative data from three independent experiments). f IL-10 production by pre-naïve B cells following
stimulation with L cells with and without CD154 expression was measured from culture supernatants by ELISA as described in (e). **P < 0.01,
***P < 0.001. IFN-γ interferon-gamma, IL interleukin
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IL-10+ B cells are enriched within the human CD27−CD38int
pre-naïve B-cell population following CD40 engagement
To investigate whether pre-naïve B cells uniquely pro-
duce IL-10, B cells were stained to identify mature naïve
(CD27−CD38lo), immature pre-naïve (CD27−CD38int),
transitional (CD27−CD38hi), and memory (CD27+) sub-
sets as previously shown (Fig. 1a) [3], and B-cell popula-
tions were assessed for IL-10 production after in vitro
stimulation by engaging CD40. The frequency of IL-10+
B cells and IL-10 levels were significantly higher in the
pre-naïve B-cell population compared with naïve B cells
and memory B cells (Fig. 1b, c, d). Stimulation of pre-
naïve B cells with CD154 was necessary to induce IL-10
production by the pre-naïve B cells, as unstimulated
cells did not produce IL-10 (Fig. 1e, f ).
IL-10+ pre-naïve B cells did not suppress cytokine
production by CD4+ T cells but were ineffective accessory
cells for CD4+ T-cell activation and promote development
of CD4+FoxP3+ T cells via IL-10
We next determined whether IL-10+ pre-naïve B cells
could regulate CD4+ T-cell cytokine production. CD4+ T
cells were stimulated with anti-CD3 and anti-CD28, and
the frequencies of CD4+INF-γ+ T cells and CD4+TNF-α+
T cells were measured by flow cytometry after 72 hours
of co-culture with B cells stimulated with CD154-L cells.
CD4+ T cells cultured alone or with naïve, pre-naïve,
and memory B cells all differentiated into INF-γ+- and
TNF-α+-producing cells at comparable frequencies. An
inhibitory effect of IL-10+ pre-naïve B cells on CD4+ T-
cell cytokine production was not observed compared
with the naïve and memory B cells (Fig. 2a, b).
Next, the influence of IL-10+ pre-naïve B cells on CD4+
T-cell activation was determined. We used an in vitro
T-cell and B-cell co-culture system employing a subopti-
mal T-cell activation signal (stimulation with soluble anti-
CD3, 5 μg/ml and soluble anti-CD28, 10 μg/ml) so that
effective T-cell proliferation was observed only after inter-
action with CD40-activated B cells. In this co-culture,
T-cell proliferation was noted only when activated B cells
were present. Naïve and memory B cells were both effect-
ive at promoting activated CD4+ T-cell proliferation,whereas pre-naïve B cells were less effective. In no cir-
cumstance did pre-naïve B cells depress CD4+ T-cell
proliferation below that manifested in the absence of co-
culture, but enhancement of CD4+ T-cell proliferation
was deficient compared with naïve and memory B cells
(Fig. 2c). In addition to their inability to promote optimal
CD4+ T-cell proliferation, pre-naïve B cells were ineffect-
ive at supporting IFN-γ and TNF-α secretion by activated
CD4+ T cells (Fig. 2d). To determine whether defective
promotion of CD4+ T-cell activation was mediated by IL-
10 produced by the activated pre-naïve B cells, CD4+
T-cell stimulation was carried out in the presence of a
blocking anti-IL-10 mAb. Neutralizing IL-10 resulted in
full recovery of the capacity of pre-naïve B cells to pro-
mote CD4+ T-cell proliferation to the level noted with the
other B-cell subsets (Fig. 2e). In addition, blocking IL-10
resulted in enhancement of cytokine production by CD4+
T cells (Fig. 2f).
A previous report showed that human CD19+CD24hi
CD38hi Bregs induced the development of CD4+FoxP3+
Tregs and this was partially mediated by IL-10 [20]. To
evaluate whether IL-10-mediated defective promotion of
CD4+ T-cell activation by the activated pre-naïve B cells
was associated with differentiation of Tregs, CD40-
activated B cells were co-cultured with CD4+CD25− T
cells and stimulated with CD3/CD28-coated beads for 5
days and frequencies of CD4+FoxP3+ T cells were
assessed. When CD4+ T cells were co-cultured with acti-
vated pre-naïve B cells but not with naïve or memory B
cells, there was an increase in FoxP3-expressing CD4+ T
cells (Fig. 2g, h). Neutralizing IL-10 in CD4+ T cell/acti-
vated pre-naïve B-cell co-culture resulted in reduced
conversion of CD4+ T cells into CD4+FoxP3+ T cells to
the level noted in co-cultures with the other B-cell sub-
sets (Fig. 2i).
Impaired expression of co-stimulatory molecules and
secretion of lower amounts of cytokine involved in T-cell
activation after CD40 signaling by pre-naïve B cells
To determine whether accessory molecule expression on
pre-naïve B cells is impaired, B-cell populations were
activated with CD154-L cells, and accessory molecule ex-

































































































































































































































































































































































































































Fig. 2 (See legend on next page.)
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Fig. 2 Activated pre-naïve B cells show IL-10-mediated ineffective promotion of CD4+ T-cell proliferation. a Representative contour plot showing
the frequencies of CD4+INF-γ+ T cells and CD4+TNF-α+ T cells measured by intracellular cytokine staining after co-culture with B cells and CD154-L
cells for 72 hours. b The frequencies of CD4+INF-γ+ T cells and CD4+TNF-α+ T cells measured as described in (a) (n = 4, cumulative data from three
independent experiments). c Effect of total B cells and each B-cell subset on CD4+ T-cell proliferation in co-culture with B cells and CD154-L cells for 5
days (n = 10, cumulative data from eight independent experiments). d IFN-γ and TNF-α secretion was measured by enzyme-linked immunosorbent
assay in the culture supernatants from experiments described in (c). e The effect of each B-cell subset on T-cell proliferation cells in co-culture
of CD4+ T cells, B cells, and CD154-L cells for 5 days cultured in medium alone or in the presence of anti-IL-10 mAb (n = 6, cumulative data
from five independent experiments). f IFN-γ and TNF-α secretion tested in supernatants from cultures as described in (e). g Representative histogram
showing frequencies of CD4+FoxP3+ T cells in co-culture with CD4+ T cells, B cells, and CD154-L cells for 5 days. h The effect of each B-cell subset on
frequencies of CD4+FoxP3+ T cells from experiments described in (g) (n = 3, cumulative data from three independent experiments). i The effect of
pre-naïve B cells on frequencies of CD4+FoxP3+ T cells from experiments described in (g) cultured in medium alone or in the presence of
anti-IL-10 mAb (n = 3, cumulative data from three independent experiments). *P < 0.05, **P < 0.01. IFN-γ interferon-gamma, IL interleukin, mAb
monoclonal antibody, TNF-α tumor necrosis factor-alpha
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CD86, CD54, and HLA-DR was found on all three B-cell
populations after CD40 stimulation for 1 day. Of note, pre-
naïve B cells expressed a lower level of CD80 compared
with naïve and memory B cells after CD40 stimulation,
whereas CD86 expression was comparable to the level of
expression on naïve and memory B cells. On day 2 of
CD40 stimulation, all three B-cell populations increased
CD80 expression, although the level expressed by pre-
naïve B cells remained substantially lower than that of the
other B-cell populations. CD86 expression was also upreg-
ulated between 24 and 48 hours by naïve and memory B
cells, whereas pre-naïve B cells downregulated CD86
expression on day 2 of CD40 stimulation. CD54 and HLA-
DR expression was comparable on all three B-cell popula-
tions. Blocking with IL-10/IL-10 receptor Abs did not
increase co-stimulatory molecule expression by any B-cell
population. However, IL-10 enhanced CD80 and CD86 ex-
pression on CD40-activated B cells and this effect was re-
versed with blocking IL-10/IL-10 receptor Abs (Fig. 3b).
To examine the effects of secretion of cytokines
involved in T-cell activation, we measured IL-6 and
TNF-α produced by the B cells after CD40 stimulation
(Fig. 3c). We found that pre-naïve B cells produced sig-
nificantly lower levels of TNF-α (27.5 ± 22.7 pg/ml) com-
pared with memory (391.3 ± 73.3 pg/ml, P < 0.001) and
naïve (52.1 ± 17.5 pg/ml, P = 0.027) B cells and produced
significantly lower levels of IL-6 (30.1 ± 22.7 pg/ml)
compared with memory B cells (137.53 ± 73 pg/ml, P =
0.015). Blocking with IL-10/IL-10 receptor Abs did not
affect the secreted levels of IL-6 and TNF-α in any B-
cell population. However, addition of IL-10 inhibited
TNF-α production by naïve and memory B cells but had
minimal effect on pre-naïve B cells. The effect of IL-10
on TNF-α production by memory B cells was reversed
by blocking with IL-10/IL-10 receptor Abs.
Antibodies produced by pre-naïve B cells are autoreactive
Stimulated immature B cells produce predominantly
autoreactive Abs [21]. We cultured pre-naïve B cellswith optimally activated CD4+ T cells to induce differen-
tiation into Ab-secreting plasma cells to test whether
secreted Abs are autoreactive. As can be seen, a large
population of CD27+CD38high plasma cells was gener-
ated (Fig. 4a). As a measure of self-reactivity, we tested
IgM Abs for binding to a defined set of Ags, including
ssDNA, dsDNA, and histone, by ELISA in culture super-
natants from 10 healthy donors. We found that IgM Abs
produced by pre-naïve B cells from 5 out of 10 donors
were reactive to ssDNA but that only 1 out of 10 naïve
B-cell cultures was reactive to anti-ssDNA (Fig. 4b). Anti-
histone or anti-DNA was produced by neither naïve nor
pre-naïve B cells in any of the donors tested. Importantly,
neutralization of IL-10 had no effect on the capacity of
pre-naïve B cells to differentiate into plasma cells (Fig. 4c).
Since previous analysis of human Ab sequences showed
that long IgH CDR3 or highly positively charged IgH
CDR3s (or both) were associated with self-reactivity of the
Abs [22, 23], we examined characteristics of the IgH
CDR3 from transitional, pre-naïve, and naïve B-cell popu-
lations (Table 1 and Additional file 1: Figure S1). By com-
paring the distribution between the productive and the
non-productive repertoires of transitional, pre-naïve, and
naïve B cells, we found that negative selection for long
and highly positive charged IgH CDR3 occurred in all
three B-cell populations. However, analysis of the product-
ive repertoires revealed that CDR3H of pre-naïve B cells
(52.5 ± 12.5 bp) was significantly longer compared with
that of the transitional (48.9 ± 12.6 bp) and the naïve
(49.0 ± 10.5 bp) B cells (P <0.01). This skewing for longer
CDR3H length in pre-naïve B cells was related to mainten-
ance of significantly longer germline D segment.
SLE pre-naïve B cells differ from normal B cells in IL-10
production and co-stimulatory molecule expression
Because SLE is associated with loss of tolerance, we ex-
amined whether regulatory activities of pre-naïve B cells
are altered in patients with SLE. In contrast to pre-naïve
B cells from healthy donors, SLE pre-naïve B cells failed
to produce IL-10 upon stimulation with CD154-L cells
Fig. 3 (See legend on next page.)
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Fig. 3 Impaired expression of co-stimulatory molecules and secretion of lower amounts of cytokine involved in T-cell activation by pre-naïve B
cells. a Mean fluorescence intensity (MFI) of CD80, CD86, CD54, and HLA-DR expression of naïve, pre-naïve, and memory B-cell population on days
0–2 after stimulation with CD154-L cells (n = 18, cumulative data from 10 independent experiments). Data are expressed as mean MFI ± standard
error (SE). b MFI of CD80 and CD86 expression of each B-cell population on day 1 of cultures described in (a) in medium alone or in the presence
of anti-IL-10+ anti-IL-10Ra, rhIL-10, and rhIL-10+ anti-IL-10+ anti-IL-10Ra (n = 18, cumulative data from 10 independent experiments). Data are
expressed as mean ± SE fold change over non-treated samples. c IL-6 and TNF-α levels in culture supernatants on day 1 of culture as described in
(b). IL-6 and TNF-α secretion in the culture supernatants was measured by multiplex assay (n = 18, cumulative data from 10 independent experiments).
Data are expressed as mean ± SE. *P < 0.05, **P < 0.01. ***P <0.001. IL-10 interleukin-10, TNF-α tumor necrosis factor-alpha, rhIL-10 recombinant IL-10,
anti-IL-10Ra anti-IL-10 receptor antibody
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of IL-10 production were low, similar to those of naïve
and memory B-cell populations (Fig. 5b, c).
Next, we evaluated whether the accessory molecule ex-
pression pattern was different in pre-naïve B cells from
the SLE patients compared with the healthy individuals
after CD40 stimulation (Fig. 5d, e). An increase in ex-
pression of CD80 was found by SLE pre-naïve B cells,
compared with healthy pre-naïve B cells, after CD40
stimulation for 1 day, whereas CD86, HLA-DR, CD54
expression was not significantly different. On day 2 of
CD40 stimulation, early downregulation of CD86 and
HLA-DR expression found in healthy pre-naïve B cells
was not found in SLE pre-naïve B cells. SLE pre-naïve B
cells continued to maintain their expression levels of
CD86 and HLA-DR for up to day 2 of CD40 stimulation.
In addition, we found that SLE B cells were more effect-
ive in stimulating CD4+ T-cell activation compared with
the healthy individuals. Of note, SLE pre-naïve B cells
promoted CD4+ T-cell proliferation comparably to naïve
and memory B-cell (Fig. 5f ).
Discussion
Pre-naïve B cells are a unique intermediate maturational
subset with some immunocompetent functions, but their
role in immune regulation has not been previously
defined. In this study, we demonstrated two distinct
functions of human peripheral pre-naïve B cells during
normal immune responses: production of autoreactive
Abs and maintenance of peripheral tolerance by auto-
regulation of their accessory cell function.
B cells with autoreactive BCRs are constantly gener-
ated by random Ig gene rearrangement during B-cell on-
togeny. It was reported in humans that approximately
half of all BCRs expressed by immature B cells are auto-
reactive [21]. Since pre-naïve B cells are developmentally
not fully mature, it was possible that Abs produced by
the pre-naïve B cells were autoreactive. In accordance
with previous findings, we found that IgM Abs produced
by pre-naïve B cells from 50 % of the normal donors
tested were reactive to ssDNA and had longer IgH
CDR3 length compared with transitional and naïve B
cells suggestive of self-reactivity [22, 23]. Though para-
doxical to B-cell tolerance, auto-Abs are known toperform some useful functions during immune re-
sponses. An example of such beneficial auto-Abs are
natural Abs, which are shown to be an essential first-line
defense against pathogens [24] and are shown to partici-
pate in the clearances of apoptotic cells [25]. In mice,
natural Abs are secreted mainly by a distinct B-cell sub-
set, B-1 cells [15], but in humans, existence of a distinct
B-cell subset similar to mouse B-1 cells is less clear, and
natural Abs are produced mainly by CD5+ B cells not
committed to a distinct lineage. Fetal and neonatal B
cells [26, 27] as well as CD5+ B cells from healthy adults
and from patients with chronic lymphocytic leukemia
and autoimmune diseases such as rheumatoid arthritis
and SLE were shown to produce natural IgM autoreac-
tive Abs [28–30]. Autoreactivity of Abs produced by the
pre-naïve B cells and the fact that these cells are CD5+
suggest that pre-naïve B cells may be one source of nat-
ural Abs in adult humans functioning to clear apoptotic
material and other auto-Ags or to provide primary
defense against certain bacterial and viral pathogens dur-
ing humoral immune response.
To maintain tolerance, most of the autoreactive imma-
ture B cells in the periphery are culled during develop-
ment before they enter the mature B-cell compartment
by a mechanism of deletion, since they are highly
susceptible to deletion by receptor cross-linking [31].
Because pre-naïve B cells may contribute to protective
autoreactive Ab production during normal immune re-
sponse, it would be a loss if these cells were completely
deleted from the repertoire. Their presence poses a risk,
however, if they could function as Ag-presenting cells
(APCs). The presence of a BCR with specificity for auto-
Ags might permit them to present auto-Ags to CD4+ T
cells. We found unique mechanisms to limit this
possibility in healthy individuals. The first mechanism
employed by the pre-naïve B cells is regulation of co-
stimulatory molecules upon receiving CD40 signal. We
found that CD40-activated pre-naïve B cells inherently
displayed lower levels of CD80 and that the more widely
and predominantly displayed CD86 was displayed only
transiently but that naïve and memory B cells continued
to upregulate both CD80 and CD86. CD80 and CD86
are well-defined potent co-stimulators that play a major
role in the activation of T cells by binding to CD28 [32].
Fig. 4 (See legend on next page.)
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Fig. 4 Antibodies produced by pre-naïve B cells are autoreactive. a Sorted pre-naïve and naïve B cells were cultured with irradiated CD4+ T cells
in anti-CD3 pre-coated microtiter wells and, after 11 days of culture, were assessed for CD38highCD27+IgD− plasma cells. Numbers represent
percentage of CD27+CD38high B cells and CD27+CD38highIgD− B cells. b Reactivity of antibodies produced by pre-naïve and naïve B cells. Culture
supernatants from experiment described in (a) from pre-naïve B cells (●) and naïve B cells (○) were analyzed for reactivity with indicated antigens,
histone, dsDNA, and ssDNA by enzyme-linked immunosorbent assay. Values indicate results from individual donors of a total of 15 tested. c Sorted
pre-naïve and naïve B cells were stimulated with anti-CD40 2 μg/ml and interleukin-21 (IL-21) 200 ng/ml in the presence and absence of anti-IL-10
monoclonal antibodies 10 μg/ml and assessed for frequencies of CD27+CD38highIgD− plasma cells at days 3, 6, and 8. Numbers represent percentage
of cells. A.U. arbitary units, dsDNA double-stranded DNA, PC plasma cells, ssDNA, single-stranded DNA
Sim et al. Arthritis Research & Therapy  (2015) 17:190 Page 11 of 15It has been suggested that CD86 is more important than
CD80 in mediating resting T-cell activation by APCs
[33] and is essential for autoreactive T-cell activation
and development for autoimmunity [34]. Early downreg-
ulation of CD86 by pre-naïve B cells may be one of the
mechanisms to block the autoimmune response from
occurring by chance. Of note, this mechanism appeared
to be independent of IL-10 secretion, even though IL-10
has been shown to regulate co-stimulatory molecule ex-
pression in dendritic cells (DCs) and macrophages by
means of the E3 ubiquitin ligase membrane-associated
ring-CH 1 (MARCH 1) [35, 36].
A second mechanism to limit stimulation of autoreactive
CD4+ T cells is through regulation of cytokine secretion.
IL-10 is one of the most important anti-inflammatory cyto-
kines regulating T-cell responses produced by macro-
phages, DCs, B cells, and various subsets of CD4+ and
CD8+ T cells [37]. IL-10 produced by the B cells is known
to mediate immunosuppression and to regulate T-cell re-
sponses directly or by induction of Tregs [20, 38–40].
However, the capacity of IL-10 produced by pre-naïve B
cells to downregulate the ability of these cells to augment
CD4+ T-cell activation has not been previously reported.
We found that pre-naïve B cells produced IL-10 uponTable 1 Characteristics of immunoglobulin heavy chain CDR3









Transitional B 109 48.9 ± 12.6 14.7 ± 5.1
Pre-naïve B 200 52.5 ± 12.5a,b 17.3 ± 5.8
Naïve B 146 49.0 ± 10.5 15.9 ± 5.2
Non-productive rearrangements
Transitional B 24 57.3 ± 10.9c 18.4 ± 5.7
Pre-naïve B 71 59.9 ± 16.5c 18.4 ± 6.0
Naïve B 39 60.3 ± 16.3c 18.4 ± 5.9
SD standard deviation
aSignificant (P < 0.05) difference between transitional and pre-naïve B cells
bSignificant (P < 0.05) difference between pre-naïve and naïve B cells
cSignificant (P< 0.01) between the productive and non-productive rearrangementsreceiving a CD40 signal and that IL-10 prevented these
cells from maximally supporting the stimulation of CD4+
T-cell proliferation and biased these cells away from sup-
porting T-cell proliferation toward participation in the dif-
ferentiation of CD4+ T cells into CD4+FoxP3+ Tregs. We
are unable to fully explain the endocrine effect of secreted
IL-10 on pre-naïve B-cell co-stimulatory function. In DCs
and monocytes, downregulation of CD86 [41, 42] and
MHC class II molecules [43, 44] was reported to be in-
volved in IL-10-mediated poor support of T-cell responses.
In contrast, it was also reported that IL-10 activates B cells
and upregulates MHC class II molecule [45, 46]. We also
found that IL-10 mediated modest upregulation of CD80
and CD86, suggesting that other mechanisms employed by
IL-10 to mediate poor support of T-cell activation exist
which counteract B-cell activation by IL-10. In addition to
production of immunoregulatory cytokine IL-10, pre-naïve
B cells secreted significantly lower amounts of T-cell acti-
vating cytokines IL-6 and TNF-α, which can further pre-
vent these cells from promoting T-cell activation.
Thus far, IL-10-producing B cells exhibiting regulatory
functions independent of secreted IgG have been classi-
fied as Bregs in both mouse and humans [8]. Stimulation
with a combination of Ag, CD154, and Toll-like receptor
ligands was reported to induce production of IL-10 by
the Bregs [8]. Phenotypically, two subsets of human IL-10-
producing Bregs were described: CD19+CD24highCD38high
immature transitional B cells and CD19+CD24hiCD27+
memory B cells [14, 47]. Pre-naïve B cells also produce
IL-10 after CD40 stimulation but are not classic Bregs
phenotypically. They are immature B cells and express
intermediate levels of CD38 and CD24 compared with the
CD19+CD24highCD38high Breg cells described previously
[3]. In addition, pre-naïve B cells appear to regulate im-
mune responses through limiting their own Ag-presenting
function, not by directly suppressing CD4+ T cells as with
Bregs. Therefore, IL-10 produced by the pre-naïve B cells
may contribute to maintenance of self-tolerance by limit-
ing the capacity to activate CD4+ T cells rather than by
directly suppressing their function.
Patients with SLE have been suggested to have a defect
in early B-cell tolerance checkpoints leading to the accu-
mulation of a large number of naïve B cells that express
BCRs that recognize self-Ags, even in the inactive phase
a Naïve B Pre-naïve B Memory B
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Fig. 5 (See legend on next page.)
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Fig. 5 Systemic lupus erythematosus (SLE) pre-naïve B cells were defective in producing interleukin-10 (IL-10) and promoted robust CD4+ T-cell
activation. a Representative contour plot showing the frequencies of IL-10-producing B cells from an SLE patient, measured as described in Fig. 1b.
b Comparison of the frequencies of IL-10-producing B cells between six patients with SLE and 10 healthy donors (cumulative data from 6
independent experiments). c Supernatants from cultures as described in (b) were tested for the presence of IL-10 by enzyme-linked immunosorbent
assay. d Representative histogram comparing CD80, CD86, CD54, and HLA-DR expression on pre-naïve B cells from a healthy individual and an SLE
patient, obtained as described in Fig. 3a. e Comparison of mean fluorescence intensity of CD80, CD86, CD54, and HLA-DR expression of pre-naïve
B cells from six healthy individuals and three SLE patients on days 0–2 (cumulative data from three independent experiments). Data are expressed as
mean ± standard error. f Representative histogram showing proliferation of T cells in co-culture with B cells from two SLE patients and two healthy
donors. Proliferation of T cells was determined by carboxyfluorescein succinimidyl ester (CFSE) dilution. *P < 0.05, **P < 0.01, ***P < 0.001. IFN-γ
interferon-gamma, MFI mean fluorescence intensity
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et al. have demonstrated that 25–50 % of the naïve B
cells in patients with SLE produced self-reactive Abs
even before they participate in immune responses [49].
However, the precise mechanisms contributing to early
tolerance defects have not been reported until recently.
In a recent study, CD19+CD24hiCD38hi Bregs from pa-
tients with SLE were found to be refractory to CD40
engagement and produced less IL-10 and lacked CD4+
T-cell suppressive capacity compared with the healthy
controls, suggesting that functional defects of Bregs
could lead to autoimmunity [14]. We found that pre-
naïve B cells from patients with SLE also showed a de-
fect in producing IL-10 following CD40 stimulation and
that their limited co-stimulatory molecule expression
upon CD40 signaling was also impaired. SLE pre-naïve B
cells expressed higher levels of CD80, CD86, and HLA-
DR after CD40 stimulation and effectively promoted
CD4+ T-cell activation compared with the healthy con-
trols. Since IL-10 and deficient co-stimulatory molecule
expression appear to be a novel mechanism of self-
tolerance employed by the pre-naïve B cells, a defect in
pre-naïve B-cell functions could lead to a break in self-
tolerance, especially in the SLE milieu, where expansion
of the pre-naïve B cells has been found [3, 4], and the
immune system is intensely activated as evidenced by el-
evated B cell-activating factor (BAFF) levels, hyperex-
pression of CD40L on T cells, and/or increased levels of
certain cytokines such as IL-21 [50–53]. In mice, BAFF
has been shown to increase IL-10 production from MZ
B cells [54]. The relevance of this to human B cells is
unknown since pre-naïve B cells respond poorly to BAFF
[3], and many patients with SLE have increased levels of
BAFF but decreased IL-10 production [55, 56]. It is intri-
guing to note that SLE pre-naïve B cells may play a
unique role in activating autoimmune CD4+T cells since
they have enhanced co-stimulatory capacity and also
more frequently express autoreactive BCR. This combin-
ation of abnormalities may make them uniquely suited
to take up and process auto-Ags and present the relevant
peptide to autoreactive CD4+ T cells, thus contributing to
the break in T-cell tolerance and the upregulation of auto-
immunity in patients with SLE.Conclusions
Our data suggest that there are inherent and IL-10-
dependent mechanisms that limit the capacity of acti-
vated pre-naïve B cells from participating in cellular
immune response, but these cells can participate in
humoral immune responses by production of auto-Abs.
Defects in these pre-naïve B-cell mechanisms in SLE
may contribute to a break in self-tolerance and could en-
hance the development of autoimmunity. Further under-
standing of the mechanisms underlying the functional
defects of pre-naïve B cells in patients with SLE could
provide insights into the pathogenesis of this complex
systemic autoimmune disease.Additional file
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